Deubzer, Hedwig, Busche, Barbara, Rönndahl, Gabi, Eikel, Daniel, Michaelis, Martin, Cinatl, Jindrich, Schulze, Sandra, Nau, Heinz, Witt, Olaf (2006) Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells. Leukemia research, 30 (9). pp. 1167-75. ISSN 0145-2126. (doi:10.1016/j.leukres.2006.01.009) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:34099)
The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. | |
Official URL: https://doi.org/10.1016/j.leukres.2006.01.009 |
Abstract
The anti-epileptic drug valproic acid harbors anti-tumoral activity in solid and leukemic tumor cell models and is currently evaluated in clinical trials. However, the plasma trough concentrations obtained in patients by common anti-epileptic dose regimens are below concentrations required for exerting anti-tumor effects in vitro. Here, we describe the identification of three novel valproic acid derivatives with superior differentiation-inducing and anti-proliferative activities in K562 bcr/abl-positive chronic myeloid leukemia cells and HL60 promyelocytic leukemia cells at achievable therapeutic VPA concentrations. These compounds reveal potent inhibition of histone deacetylase activity, induction of p21Cip/Waf expression as well as low toxicity on CD34+ bone marrow cells.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1016/j.leukres.2006.01.009 |
Subjects: | R Medicine > RM Therapeutics. Pharmacology |
Divisions: | Divisions > Division of Natural Sciences > Biosciences |
Depositing User: | Martin Michaelis |
Date Deposited: | 05 Jun 2013 20:54 UTC |
Last Modified: | 09 Mar 2023 11:32 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/34099 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):